ProSpec
Production of Recombinant Proteins, Cytokines, Growth Factors, and Chemokines
StartupProSpec is a Rehovot-based startup in the Retail Platforms sector, established in 2000. Production of Recombinant Proteins, Cytokines, Growth Factors, and Chemokines. The company has 1-10 employees. Core technologies: Biologicals, Cells.
The company follows a B2B business model. Product stage: Released. The company holds 1 patent.
- StageMature
- ProductReleased
- ModelB2B
- Employees1-10
- HQRehovot
- DistrictCenter District
- Last RoundUndisclosed
1 article covered by sources including www.bionovuslifesciences.com.au.
What does ProSpec do?
ProSpec is a biotechnology company providing highly purified proteins worldwide. The company specializes in the production and purification of recombinant cytokines and chemokines from bacterial systems for the needs of the research community. Its main product lines include cytokine-related products for cancer, apoptosis, development, endocrinology, immunology, neuroscience, proteases, and stem cell research. ProSpec's research team and scientists have assembled more than 7,000 recombinant proteins, peptides, and antibodies to address researchers' needs. Its proteins, which include interferons, interleukins, bone morphogenic proteins, tumor necrosis factors, leptins, and stem cell factors, are all rigorously tested.
What sector is ProSpec in?
ProSpec operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, Biomaterials & Tissue Engineering, Retail Platforms, Goods, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.
Where is ProSpec located?
ProSpec is based in HaMada Street 8, Rehovot, Israel, Center District. The company also has offices abroad.